Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Assets: 2022-2025

Historic Assets for InMed Pharmaceuticals (INM) over the last 4 years, with Jun 2025 value amounting to $15.6 million.

  • InMed Pharmaceuticals' Assets rose 27.67% to $13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.4 million, marking a year-over-year increase of 27.67%. This contributed to the annual value of $15.6 million for FY2025, which is 31.78% up from last year.
  • Latest data reveals that InMed Pharmaceuticals reported Assets of $15.6 million as of FY2025, which was up 31.78% from $11.8 million recorded in FY2024.
  • InMed Pharmaceuticals' Assets' 5-year high stood at $15.6 million during FY2025, with a 5-year trough of $11.8 million in FY2024.
  • In the last 3 years, InMed Pharmaceuticals' Assets had a median value of $14.1 million in 2023 and averaged $13.8 million.
  • Per our database at Business Quant, InMed Pharmaceuticals' Assets decreased by 16.19% in 2024 and then soared by 31.78% in 2025.
  • InMed Pharmaceuticals' Assets (Yearly) stood at $12.8 million in 2022, then climbed by 10.31% to $14.1 million in 2023, then fell by 16.19% to $11.8 million in 2024, then spiked by 31.78% to $15.6 million in 2025.